On October 21, 2026, NeOnc Technologies Holdings, Inc. announced the signing of a Memorandum of Understanding with the Department of Health – Abu Dhabi. This collaboration aims to enhance research and clinical capabilities in oncology and central nervous system therapeutics. The partnership highlights NeOnc's commitment to advancing healthcare in the Emirate of Abu Dhabi
Company Information
Company
NeOnc Technologies
Location
23975 PARK SORRENTO
Westlake Village, California, United States
About
NeOnc is the developer of a proprietary, patented platform technology that can potentially transport pharma-based therapeutics directly to the brain without the normal boundary restrictions imposed by the body’s Blood-Brain Barrier (BBB). Using NeOnc’s formulations, pharma companies that have limited success with their CNS therapeutics because of current delivery restrictions may be able to provide patients with potentially more effective treatments.